The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Event Date:
4 – 5 December 2020
Location:
Virtual Meeting
View ProgramView Program

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development. Richmond Pharmacology’s CEO, Jorg Taubel M.D. will be presenting three posters covering the following themes:

  • Meta-analysis of the effect of a meal on QTcF
  • Effect of Glucose Alone and in Collaboration with Moxifloxacin on Cardiac Repolaration in Male and Female Patents with Type I Diabetes
  • Effects of Progesterone and Estradiol on Subintervals over the Course of a Menstrual Cycle

Learn more about our Japanese Bridging Studies here or by using the View Publications link below.

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more